Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Cheryl Galt who wrote (25767)	9/25/1998 3:50:00 AM
From: Skeeter Bug	Read Replies (1) \| Respond to of 32384

cheryl, sorry to hear about your pain. i'd say i can feel it with you but i'm too busy worrying about my own pain ;-) it is not wise, imho, to get emotional over a stock. henry surely has as he was instrumental in its genesis. that is understandable. i'd buy puts on lgnd without a second thought if i felt it was way overvalued and felt lucky. right now, i feel it is undervalued and bought my leap - lgndw. i hope this stock goes high enough where i consider put options on it ;-)

To: Cheryl Galt who wrote (25767)	9/25/1998 8:07:00 AM
From: Henry Niman	Read Replies (3) \| Respond to of 32384

Cheryl, I have never had a problem with diversity and most investors welcome it. My concerns are more with misleading info, which is common here and much more so on Yahoo (actually, outright lies are much too common on Yahoo, especially in the area of handles and personal attacks). Most of the naysayers here just talk about price, and I'm not convinced that they know much of anything about price or fundamentals. They make many guesses on price and then pick the predictions that fit. On fundamentals, they try the "something is wrong" approach without ever defining the something. I think that LGND's sharp turnaround was due in part because investors began to see through the constant negative posts here, and they realized that on Yahoo, there was a very concerted effort to discredit me and knock LGND's price.

To: Cheryl Galt who wrote (25767)	9/25/1998 8:20:00 AM
From: Henry Niman	Respond to of 32384

I think that there were several reasons for LGND's rally this week. As I have said before, Biotechs can easily be view as having the glass half full or half empty. The news that came out this weekend fit into that category. The San Diego Union ran an article on Biotech recovery, the NY Times had a huge artucle in SRGN, and OnlineInvestor ran a story on LGND and board comments, and LGND's road show was about to begin. A half empty analysis of the above could conclude that the rally (seen in San Diego Biotechs and elsewhere) was just a dead cat bounce. Biotechs had been battered, but the still have no earnings, the market is still jittery, and lows need to be tested again (and for Biotechs, those lows are very low lows). The SRGN article just showed that now LGND would follow the same course as SRGN. Investors would take a bigger beating and LGND would be sold for a song. The OnlineInvestor story could be read as: eventually LGND will move higher, but not now and the over-abundance of frivolous posts merely drown out any useful info on the threads. The fourth negative was the upcoming Bear Stearns presentation, which would confirm to some that indeed "something was wrong". Of course LGND move up almost 50% this week, so I think that the half full view prevailed.